scispace - formally typeset
M

Michael Karin

Researcher at University of California, San Diego

Publications -  753
Citations -  246120

Michael Karin is an academic researcher from University of California, San Diego. The author has contributed to research in topics: IκB kinase & Signal transduction. The author has an hindex of 236, co-authored 704 publications receiving 226485 citations. Previous affiliations of Michael Karin include Sanford-Burnham Institute for Medical Research & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2

TL;DR: It is shown that TBK1 triggers an antiapoptotic response by controlling a specific RelA/p65 phosphorylation event, which results in inducible expression of plasminogen activator inhibitor-2 (PAI-2) and transglutaminase 2 (TG2), which cross-links and inactivates procaspase-3.
Journal ArticleDOI

Ikappa B kinaseβ/nuclear factor‐κB activation controls the development of liver metastasis by way of interleukin‐6 expression

TL;DR: Observations suggest that IKKβ/NF‐κB activation controls the development of liver metastasis by way of IL‐6 expression and is a potential target for theDevelopment of antimetastatic drugs.
Journal ArticleDOI

Mitogen activated protein kinases as targets for development of novel anti-inflammatory drugs.

TL;DR: The pros and cons of targeting MAPKs in the treatment of chronic inflammatory disease are discussed and the possible mechanisms through which such inhibitors may interfere with inflammation are discussed.